Philippines Seizes $21 Million in Counterfeit Goods, Including Kylinbar E-Cigarettes

Mar.13.2025
Philippines Seizes $21 Million in Counterfeit Goods, Including Kylinbar E-Cigarettes
Philippine Customs has sealed a warehouse holding counterfeit goods, including Kylinbar disposable e-cigarettes, valued at approximately 1.2 billion pesos ($21 million). The warehouse operator could face charges.

Key Points:

 

1. A warehouse in the Philippines was raided and found to contain $12 billion pesos ($210 million) worth of suspected illegal e-cigarettes and counterfeit goods.

 

2. The products seized involved the Kylinbar brand of disposable e-cigarettes.

 

3. The warehouse management party may face legal charges if they fail to provide legal import documentation within 15 days.

 


 

2Firsts, reporting from Shenzhen - The Philippine Bureau of Customs (BOC) seized a warehouse in Malabon City, allegedly storing approximately 1.2 billion pesos ($21 million) worth of suspicious illegal e-cigarettes and counterfeit goods.

 

Bienvenido Rubio, the Customs Commissioner, stated at a press conference on Wednesday that the items seized included disposable e-cigarettes, shoes, bags, and cosmetics.

 

Verne Enciso, Director of the Customs Intelligence and Investigation Service (CIIS), said that upon receiving authorization from the Customs Director, they immediately went to a warehouse in Malabon City. 

 

The CIIS team and investigators from the Manila International Container Port (MICP) found disposable e-cigarettes from Kylinbar in the warehouse without labels from the Bureau of Internal Revenue (BIR) and Department of Trade and Industry (DTI).

 

The investigation team temporarily sealed the warehouse and planed to conduct an inventory of the items with customs inspectors, CIIS, the Enforcement and Security Service (ESS), and warehouse representatives. 

 

Warehouse operators were required to provide documents proving the legal acquisition and tax payment of imported goods within 15 days of receiving the authorization letter, or face potential charges under Articles 1113, 117, and 1400 of the Customs Modernization and Tariff Act (CMTA)


They may also face charges under the Intellectual Property Code of the Philippines or Republic Act 8293.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Shares Drop 18.6% in Nasdaq Debut, Testing Hookah’s Move Toward Public Markets
AIR Global’s Nasdaq debut under ticker AIIR ended with a 18.6% first-day decline, giving the global hookah industry a rare public-market reference point. Beyond one company’s share move, the listing raises a broader question: can a culturally rooted, fragmented and venue-based category evolve into a more scalable and investable consumer sector?
Special Report
May.19
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japanese Tobacco (JT) reports Q1 2026 revenue of 924 billion yen, a 15.2% increase; operating profit rises 24.7%.
May.08 by 2FIRSTS.ai